Interleukin-21 in T cell-mediated diseases.

Area of Science:

• Immunology
• Cell Biology
• Pathology

Background:

• Interleukin-21 (IL-21) is a cytokine produced by activated T cells and natural killer T cells.
• IL-21 is implicated in tissue-damaging T cell responses across various organs, including the gut, skin, pancreas, and joints.
• Its pathogenic role is attributed to enhancing the functional activities of immune and non-immune cells.

Purpose of the Study:

• To review current knowledge on the expression and function of IL-21.
• To elucidate the role of IL-21 in T cell-mediated pathologies.
• To highlight IL-21 as a potential target for therapeutic intervention.

Main Methods:

• Literature review of existing studies on IL-21.
• Analysis of research on IL-21's role in T cell-mediated diseases.
• Synthesis of findings on IL-21 blockade in preclinical models.

Main Results:

• IL-21 enhances the functional activities of multiple immune and non-immune cells, contributing to tissue damage.
• Studies demonstrate that blocking IL-21 can limit the progression of T cell-mediated inflammatory diseases in mouse models.
• IL-21 plays a critical role in the pathogenesis of various organ-specific inflammatory conditions.

Conclusions:

• IL-21 is a key mediator in T cell-driven inflammatory diseases.
• Targeting IL-21 presents a promising strategy for managing inflammatory pathologies.
• Further research into IL-21's mechanisms and therapeutic blockade is warranted.